Your browser doesn't support javascript.
loading
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Bath, Philip M; Woodhouse, Lisa J; Appleton, Jason P; Beridze, Maia; Christensen, Hanne; Dineen, Robert A; Duley, Lelia; England, Timothy J; Flaherty, Katie; Havard, Diane; Heptinstall, Stan; James, Marilyn; Krishnan, Kailash; Markus, Hugh S; Montgomery, Alan A; Pocock, Stuart J; Randall, Marc; Ranta, Annemarei; Robinson, Thompson G; Scutt, Polly; Venables, Graham S; Sprigg, Nikola.
Affiliation
  • Bath PM; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK; Stroke, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK. Electronic address: philip.bath@nottingham.ac.uk.
  • Woodhouse LJ; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Appleton JP; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK; Stroke, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.
  • Beridze M; Hospital of War Veterans, Tbilisi, Georgia.
  • Christensen H; Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Department of Neurology, Copenhagen, Denmark.
  • Dineen RA; Radiological Sciences, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Duley L; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • England TJ; Vascular Medicine, Division of Medical Sciences & GEM, University of Nottingham, Nottingham, UK.
  • Flaherty K; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Havard D; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Heptinstall S; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • James M; Health Economics, Division of Rehabilitation and Ageing, University of Nottingham, Nottingham, UK.
  • Krishnan K; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK; Stroke, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.
  • Markus HS; Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Montgomery AA; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
  • Pocock SJ; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
  • Randall M; Department of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Ranta A; Department of Neurology, Wellington Hospital and University of Otago, Wellington, New Zealand.
  • Robinson TG; Department of Cardiovascular Sciences and NIHR Leicester Cardiovascular Research Centre, University of Leicester, Leicester, UK.
  • Scutt P; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Venables GS; Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Sprigg N; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK; Stroke, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.
Lancet ; 391(10123): 850-859, 2018 03 03.
Article in En | MEDLINE | ID: mdl-29274727

Full text: 1 Database: MEDLINE Main subject: Ticlopidine / Brain Ischemia / Aspirin / Dipyridamole Type of study: Clinical_trials / Etiology_studies / Guideline / Health_technology_assessment / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte / Europa / Oceania Language: En Journal: Lancet Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ticlopidine / Brain Ischemia / Aspirin / Dipyridamole Type of study: Clinical_trials / Etiology_studies / Guideline / Health_technology_assessment / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte / Europa / Oceania Language: En Journal: Lancet Year: 2018 Type: Article